{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:10:03Z","timestamp":1776179403113,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T00:00:00Z","timestamp":1337817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s11910-012-0284-5","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T16:29:32Z","timestamp":1337790572000},"page":"466-473","source":"Crossref","is-referenced-by-count":44,"title":["Sodium and Fluid Management in Acute Brain Injury"],"prefix":"10.1007","volume":"12","author":[{"given":"Wendy L.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,24]]},"reference":[{"issue":"4","key":"284_CR1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1385\/NCC:1:4:435","volume":"1","author":"LL Larive","year":"2004","unstructured":"Larive LL, Rhoney DH, Parker Jr D, et al. Introducing hypertonic saline for cerebral edema: an academic center experience. Neurocrit Care. 2004;1(4):435\u201340.","journal-title":"Neurocrit Care"},{"issue":"5","key":"284_CR2","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/foc.2007.22.5.13","volume":"22","author":"A Raslan","year":"2007","unstructured":"Raslan A, Bhardwaj A. Medical management of cerebral edema. Neurosurg Focus. 2007;22(5):E12.","journal-title":"Neurosurg Focus"},{"key":"284_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.20788","volume":"59","author":"A Bhardwaj","year":"2006","unstructured":"Bhardwaj A. Neurological impact of vasopressin dysregulation and hyponatremia. Ann Neurol. 2006;59:229\u201336.","journal-title":"Ann Neurol"},{"key":"284_CR4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00075198-200404000-00009","volume":"10","author":"A Bhardwaj","year":"2004","unstructured":"Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care. 2004;10:126\u201331.","journal-title":"Curr Opin Crit Care"},{"key":"284_CR5","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","volume":"342","author":"HJ Androgu\u00e9","year":"2000","unstructured":"Androgu\u00e9 HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"284_CR6","first-page":"129","volume":"8","author":"K Bradshaw","year":"2008","unstructured":"Bradshaw K, Smith M. Disorders of sodium balance after brain injury.: continuing education in anesthesia. Crit Care Pain. 2008;8(4):129\u201333.","journal-title":"Crit Care Pain"},{"key":"284_CR7","doi-asserted-by":"crossref","unstructured":"Paredes-Andrade E, Solid C, Rockswold SB, et al. Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities. Neurocrit Care. 2011 Jul 2. Epub ahead of print.","DOI":"10.1007\/s12028-011-9574-z"},{"key":"284_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1445-2197.2006.03674.x","volume":"76","author":"AA Adamides","year":"2006","unstructured":"Adamides AA, Winter CD, Lewis PM, et al. Current controversies in the management of patients with severe traumatic brain injury. ANZ J Surg. 2006;76:163\u201374.","journal-title":"ANZ J Surg"},{"key":"284_CR9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12028-010-9477-4","volume":"14","author":"AN Hays","year":"2011","unstructured":"\u2022 Hays AN, Lazaridis C, Neyens R, et al. Osmotherapy: use among neurointensivists. Neurocrit Care. 2011;14:222\u20138. This revealing survey of neurointensivists shows the current state of practice in osmotherapy, including how much study is needed to come together as a practice.","journal-title":"Neurocrit Care"},{"issue":"20","key":"284_CR10","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM200005183422006","volume":"342","author":"HJ Androgue","year":"2000","unstructured":"Androgue HJ, Madias NE. Hypernatremia. NEJM. 2000;342(20):1493\u20139.","journal-title":"NEJM"},{"key":"284_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/physrev.00017.2003","volume":"84","author":"J Antunes-Rodrigues","year":"2004","unstructured":"Antunes-Rodrigues J, de Castro M, Elias LL, et al. Neuroendocrine control of body fluid metabolism. Physiol Rev. 2004;84:169\u2013208.","journal-title":"Physiol Rev"},{"key":"284_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5049\/EBP.2009.7.2.51","volume":"7","author":"DK Kim","year":"2009","unstructured":"\u2022 Kim DK, Joo KW. Hyponatremia in patients with neurologic disorders. Electrolyte Blood Press. 2009;7:51\u20137. A timely and relevant review for a common problem in neurologic patients.","journal-title":"Electrolyte Blood Press"},{"issue":"4","key":"284_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bpa.2007.07.002","volume":"21","author":"C Tomasino","year":"2007","unstructured":"Tomasino C. Volume and electrolyte management. Best Pract Res Anesthesiol. 2007;21(4):497\u2013516.","journal-title":"Best Pract Res Anesthesiol"},{"issue":"2","key":"284_CR14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12028-011-9585-9","volume":"15","author":"AA Rabinstein","year":"2011","unstructured":"Rabinstein AA, Bruder N. Management of hyponatremia and volume contraction. Neurocrit Care. 2011;15(2):354\u201360.","journal-title":"Neurocrit Care"},{"key":"284_CR15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1385\/NCC:6:1:72","volume":"06","author":"BR Nathan","year":"2007","unstructured":"Nathan BR. Cerebral correlates of hyponatremia. Neurocrit Care. 2007;06:72\u20138.","journal-title":"Neurocrit Care"},{"issue":"1","key":"284_CR16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-008-9152-1","volume":"11","author":"WL Wright","year":"2009","unstructured":"Wright WL, Asbury WH, Gilmore JL, et al. Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care. 2009;11(1):6\u201313.","journal-title":"Neurocrit Care"},{"key":"284_CR17","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2006.05.003","volume":"119","author":"RH Sterns","year":"2006","unstructured":"Sterns RH, Silver SM. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med. 2006;119:S12\u20136.","journal-title":"Am J Med"},{"key":"284_CR18","doi-asserted-by":"crossref","unstructured":"Sterns RH, Cappuccio JD, Silver SM, et al. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994;1522.","DOI":"10.1681\/ASN.V481522"},{"key":"284_CR19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/CCM.0b013e31819c1933","volume":"37","author":"M Froelich","year":"2009","unstructured":"Froelich M, Ni Q, Wess C, et al. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37:1433\u201341.","journal-title":"Crit Care Med"},{"key":"284_CR20","unstructured":"Parra A: \u201cHypertonic Saline,\u201d adult neurocritical care protocols. Revision 04\/01\/2010. www.universityhealthsystem.com"},{"key":"284_CR21","first-page":"73","volume-title":"Handbook of neurocritical care","author":"M Koenig","year":"2011","unstructured":"Koenig M. Cerebral edema and intracranial hypertension. In: Bhardwaj A, Mirski MA, editors. Handbook of neurocritical care. 2nd ed. New York: Springer; 2011. p. 73\u201388.","edition":"2"},{"key":"284_CR22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1212\/01.wnl.0000304042.05557.60","volume":"70","author":"MA Koenig","year":"2008","unstructured":"Koenig MA, Bryan M, Lewin JL, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023\u20139.","journal-title":"Neurology"},{"key":"284_CR23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12028-009-9238-4","volume":"11","author":"CH Woo","year":"2009","unstructured":"\u2022 Woo CH, Rao VA, Sheridan W, et al. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia. Neurocrit Care. 2009;11:228\u201334. A novel approach to administering hypertonic saline, this sliding-scale method was well studied and may provide guidance for novel users.","journal-title":"Neurocrit Care"},{"key":"284_CR24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12028-008-9118-3","volume":"9","author":"SG Keyrouz","year":"2008","unstructured":"Keyrouz SG, Dhar R, Diringer MN. Variation in osmotic response to sustained mannitol administration. Neurocrit Care. 2008;9:204\u20139.","journal-title":"Neurocrit Care"},{"key":"284_CR25","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/STROKEAHA.107.490193","volume":"38","author":"J Bardutzky","year":"2007","unstructured":"Bardutzky J, Schwab S. Antiedema therapy in ischemic stroke. Stroke. 2007;38:3084\u201394.","journal-title":"Stroke"},{"issue":"1","key":"284_CR26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12028-008-9179-3","volume":"11","author":"T Murphy","year":"2009","unstructured":"Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care. 2009;11(1):14\u20139.","journal-title":"Neurocrit Care"},{"key":"284_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12028-010-9366-x","volume":"14","author":"R Dhar","year":"2010","unstructured":"Dhar R, Murphy-Human T. A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury. Neurocrit Care. 2010;14:97\u2013102.","journal-title":"Neurocrit Care"},{"key":"284_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12028-010-9379-5","volume":"13","author":"AM Naidech","year":"2010","unstructured":"Naidech AM, Paparello J, Leibling SM. Use of conivaptan (Vaprisol) for hyponatremic neuro-ICU patients. Neurocrit Care. 2010;13:57\u201361.","journal-title":"Neurocrit Care"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-012-0284-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-012-0284-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-012-0284-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T04:37:15Z","timestamp":1642307835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-012-0284-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,24]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1007\/s11910-012-0284-5","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,24]]}}}